Edition:
Deutschland

Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

184.27USD
13 Aug 2018
Change (% chg)

$0.27 (+0.15%)
Prev Close
$184.00
Open
$183.47
Day's High
$184.92
Day's Low
$183.37
Volume
296,658
Avg. Vol
530,788
52-wk High
$237.01
52-wk Low
$142.83

AGN.N

Chart for AGN.N

About

Allergan plc is a specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of brand name pharmaceutical products, medical aesthetics, biosimilar and over-the-counter pharmaceutical products. The Company operates through three segments: US Specialized Therapeutics, US... (more)

Buy/Sell

Sell Hold Buy
2.04 Mean rating from 23 analysts

Overall

Beta: 1.17
Market Cap(Mil.): $69,117.80
Shares Outstanding(Mil.): 334.31
Dividend: 0.70
Yield (%): 1.35

Deals of the day-Mergers and acquisitions

Aug 3 The following bids, mergers, acquisitions and disposals were reported by 2030 GMT on Friday:

U.S. tax cuts prompt rethink by some 'inverted' companies

WASHINGTON, Aug 3 A few U.S. companies that moved offshore in a wave of inversion deals are considering returning to the United States now that domestic tax rates are lower and tax policing is tougher abroad, attorneys and consultants said.

Deals of the day-Mergers and acquisitions

Aug 3 The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday:

US STOCKS-Futures inch higher ahead of U.S. jobs report

Aug 3 U.S. stock index futures rose slightly on Friday ahead of the July jobs report, while the ongoing trade dispute between the United States and China weighed on investor sentiment.

Spain's Almirall bets on dermatology with $650 million U.S. deal

Spanish pharmaceutical company Almirall said on Friday it had agreed to buy five dermatology brands from U.S. company Allergan for up to $650 million in cash.

UPDATE 1-Spain's Almirall bets on dermatology with $650 mln U.S. deal

Aug 3 Spanish pharmaceutical company Almirall said on Friday it had agreed to buy five dermatology brands from U.S. company Allergan for up to $650 million in cash.

Spain's Almirall to buy U.S. dermatology portfolio from Allergan

Aug 3 Spanish pharmaceutical company Almirall SA said on Friday it has agreed to buy a portfolio of five brands from U.S. firm Allergan for up to $650 million in cash.

Photo

Allergan sues Pfizer over costs of opioid litigation

Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from a company Pfizer bought.

UPDATE 1-Allergan sues Pfizer over costs of opioid litigation

Aug 2 Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from a company Pfizer bought.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.12%
Rohstoffe +0.16%
Industrie +0.11%
Konjunktur abhängige Waren & Dienstleistungen +0.09%
Konjunktur unabhängige Waren & Dienstleistungen +0.02%
Finanzindustrie +0.06%
Pharma +0.06%
Technologie +0.30%
Telekommunikation +0.08%